{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:05:26Z","timestamp":1792109126492,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Isolated lung perfusion (ILP) is an ideal model to study treatment effects on a variety of pathologies. As published research mostly relies on rejected donor lungs or animal organs, this study investigates the use of surgically resected human lobes as an alternative and novel model for personalized experimental research. Ten surgically resected lobes were perfused in acellular and normothermic condition. The indication for surgery was lung cancer. Perfusion and ventilation were adapted to the size of the lobes and both functional and metabolic parameters were assessed during ILP. Patients (age 67.5\u2009y (59\u201381)|\u2640n\u2009=\u20093|\u2642n\u2009=\u20097) underwent anatomic pulmonary lobectomy. Ischemic time between arterial ligation and ILP was 226\u2009minutes (161\u2013525). Median duration of ILP was 135 (87\u2013366) minutes. Gas exchange and mechanical respiratory parameters remained steady during ILP (pulmonary venous pO<jats:sub>2<\/jats:sub> 196(151\u2013219) mmHg | peak AWP: 14.5(11\u201322) cmH<jats:sub>2<\/jats:sub>O). Metabolism stayed constant during ILP (Glucose consumption: 1.86\u2009mg\/min\/L<jats:sub>TLC<\/jats:sub> (95%CI: \u22122.09 to \u22121.63) | lactate production: 0.005\u2009mmol\/min\/ L<jats:sub>TLC<\/jats:sub> (95%CI: 0.004 to 0.007)). ILP of surgically resected human lobes is a feasible and promising method. By maintaining a near physiological setting, this model may pave the way for future experimental lung research including cancer research, transplantation, physiology, pharmacology and mechanical ventilation.<\/jats:p>","DOI":"10.1038\/s41598-019-48719-8","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T10:03:05Z","timestamp":1566381785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Implementation of an experimental isolated lung perfusion model on surgically resected human lobes"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-0832","authenticated-orcid":false,"given":"Alexis","family":"Slama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Raber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Hedderich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Stockhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Heged\u00fcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Theegarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Ploenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-991X","authenticated-orcid":false,"given":"Clemens","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"key":"48719_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0003-4975(10)65582-8","volume":"10","author":"DW Jirsch","year":"1970","unstructured":"Jirsch, D. W., Fisk, R. L. & Couves, C. M. Ex vivo evaluation of stored lungs. Ann Thorac Surg 10, 163\u2013168, https:\/\/doi.org\/10.1016\/s0003-4975(10)65582-8 (1970).","journal-title":"Ann Thorac Surg"},{"key":"48719_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0003-4975(10)65040-0","volume":"16","author":"DL Modry","year":"1973","unstructured":"Modry, D. L. et al. Hypothermic perfusion preservation of the isolated dog lung. Ann Thorac Surg 16, 583\u2013597, https:\/\/doi.org\/10.1016\/s0003-4975(10)65040-0 (1973).","journal-title":"Ann Thorac Surg"},{"key":"48719_CR3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-5223(19)41388-3","volume":"74","author":"DL Modry","year":"1977","unstructured":"Modry, D. L., Chiu, C. J. & Hinchey, E. J. The roles of ventilation and perfusion in lung metabolism. J Thorac Cardiovasc Surg 74, 275\u2013285 (1977).","journal-title":"J Thorac Cardiovasc Surg"},{"key":"48719_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1055\/s-2007-1012003","volume":"44","author":"A Linder","year":"1996","unstructured":"Linder, A. et al. The ex-vivo isolated, perfused human lung model: description and potential applications. Thorac Cardiovasc Surg 44, 140\u2013146, https:\/\/doi.org\/10.1055\/s-2007-1012003 (1996).","journal-title":"Thorac Cardiovasc Surg"},{"key":"48719_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(00)04195-7","volume":"357","author":"S Steen","year":"2001","unstructured":"Steen, S. et al. Transplantation of lungs from a non-heart-beating donor. Lancet 357, 825\u2013829, https:\/\/doi.org\/10.1016\/S0140-6736(00)04195-7 (2001).","journal-title":"Lancet"},{"key":"48719_CR6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/0003-4975(93)91016-g","volume":"55","author":"S Steen","year":"1993","unstructured":"Steen, S., Sjoberg, T., Massa, G., Ericsson, L. & Lindberg, L. Safe pulmonary preservation for 12 hours with low-potassium-dextran solution. Ann Thorac Surg 55, 434\u2013440, https:\/\/doi.org\/10.1016\/0003-4975(93)91016-g (1993).","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"48719_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0003-4975(03)00191-7","volume":"76","author":"Stig Steen","year":"2003","unstructured":"Steen, S. et al. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 76, 244\u2013252; discussion 252, https:\/\/doi.org\/10.1016\/s0003-4975(03)00191-7 (2003).","journal-title":"The Annals of Thoracic Surgery"},{"key":"48719_CR8","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.athoracsur.2007.01.033","volume":"83","author":"S Steen","year":"2007","unstructured":"Steen, S. et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 83, 2191\u20132194, https:\/\/doi.org\/10.1016\/j.athoracsur.2007.01.033 (2007).","journal-title":"Ann Thorac Surg"},{"key":"48719_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.athoracsur.2005.08.015","volume":"81","author":"P Wierup","year":"2006","unstructured":"Wierup, P. et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg 81, 460\u2013466, https:\/\/doi.org\/10.1016\/j.athoracsur.2005.08.015 (2006).","journal-title":"Ann Thorac Surg"},{"key":"48719_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.athoracsur.2008.09.049","volume":"87","author":"R Ingemansson","year":"2009","unstructured":"Ingemansson, R. et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 87, 255\u2013260, https:\/\/doi.org\/10.1016\/j.athoracsur.2008.09.049 (2009).","journal-title":"Ann Thorac Surg"},{"key":"48719_CR11","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1111\/j.1600-6143.2009.02775.x","volume":"9","author":"M Cypel","year":"2009","unstructured":"Cypel, M. et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 9, 2262\u20132269, https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02775.x (2009).","journal-title":"Am J Transplant"},{"key":"48719_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.healun.2008.09.003","volume":"27","author":"M Cypel","year":"2008","unstructured":"Cypel, M. et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 27, 1319\u20131325, https:\/\/doi.org\/10.1016\/j.healun.2008.09.003 (2008).","journal-title":"J Heart Lung Transplant"},{"key":"48719_CR13","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1056\/NEJMoa1014597","volume":"364","author":"M Cypel","year":"2011","unstructured":"Cypel, M. et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 364, 1431\u20131440, https:\/\/doi.org\/10.1056\/NEJMoa1014597 (2011).","journal-title":"N Engl J Med"},{"key":"48719_CR14","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/j.1600-6143.2012.04027.x","volume":"12","author":"C Aigner","year":"2012","unstructured":"Aigner, C. et al. Clinical ex vivo lung perfusion\u2013pushing the limits. Am J Transplant 12, 1839\u20131847, https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04027.x (2012).","journal-title":"Am J Transplant"},{"key":"48719_CR15","unstructured":"Slama, A. et al. In 1st European Cardio Thoracic Transplant Association Meeting (ECTTA) (Budapest, 2014)."},{"key":"48719_CR16","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jtcvs.2012.08.011","volume":"144","author":"A Wallinder","year":"2012","unstructured":"Wallinder, A. et al. Transplantation of initially rejected donor lungs after ex vivo lung perfusion. J Thorac Cardiovasc Surg 144, 1222\u20131228, https:\/\/doi.org\/10.1016\/j.jtcvs.2012.08.011 (2012).","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"48719_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/ejcts\/ezt250","volume":"45","author":"A. Wallinder","year":"2013","unstructured":"Wallinder, A. et al. Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study. Eur J Cardiothorac Surg 45, 40\u201344; discussion 44\u201345, https:\/\/doi.org\/10.1093\/ejcts\/ezt250 (2014).","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"key":"48719_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.healun.2011.10.008","volume":"31","author":"B Zych","year":"2012","unstructured":"Zych, B. et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 31, 274\u2013281, https:\/\/doi.org\/10.1016\/j.healun.2011.10.008 (2012).","journal-title":"J Heart Lung Transplant"},{"key":"48719_CR19","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.healun.2012.01.331","volume":"31","author":"JH Dark","year":"2012","unstructured":"Dark, J. H. et al. 323 Successful Transplantation of Unusable Donor Lungs Using Ex-Vivo Lung Perfusion: The Newcastle Experience. The Journal of Heart and Lung Transplantation 31, S115, https:\/\/doi.org\/10.1016\/j.healun.2012.01.331 (2012).","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"48719_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/tri.12295","volume":"27","author":"F Valenza","year":"2014","unstructured":"Valenza, F. et al. Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation. Transpl Int 27, 553\u2013561, https:\/\/doi.org\/10.1111\/tri.12295 (2014).","journal-title":"Transpl Int"},{"key":"48719_CR21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/ejcts\/ezu245","volume":"46","author":"E Sage","year":"2014","unstructured":"Sage, E. et al. Lung transplantation from initially rejected donors after ex vivo lung reconditioning: the French experience. Eur J Cardiothorac Surg 46, 794\u2013799, https:\/\/doi.org\/10.1093\/ejcts\/ezu245 (2014).","journal-title":"Eur J Cardiothorac Surg"},{"key":"48719_CR22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.healun.2017.02.011","volume":"36","author":"A Slama","year":"2017","unstructured":"Slama, A. et al. Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial. J Heart Lung Transplant 36, 744\u2013753, https:\/\/doi.org\/10.1016\/j.healun.2017.02.011 (2017).","journal-title":"J Heart Lung Transplant"},{"key":"48719_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S2213-2600(18)30136-X","volume":"6","author":"G Warnecke","year":"2018","unstructured":"Warnecke, G. et al. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. Lancet Respir Med 6, 357\u2013367, https:\/\/doi.org\/10.1016\/S2213-2600(18)30136-X (2018).","journal-title":"Lancet Respir Med"},{"key":"48719_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S2213-2600(16)30323-X","volume":"5","author":"JC Yeung","year":"2017","unstructured":"Yeung, J. C. et al. Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study. Lancet Respir Med 5, 119\u2013124, https:\/\/doi.org\/10.1016\/S2213-2600(16)30323-X (2017).","journal-title":"Lancet Respir Med"},{"key":"48719_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.healun.2007.07.033","volume":"26","author":"I Inci","year":"2007","unstructured":"Inci, I. et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant 26, 1054\u20131060, https:\/\/doi.org\/10.1016\/j.healun.2007.07.033 (2007).","journal-title":"J Heart Lung Transplant"},{"key":"48719_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0022-5223(95)70232-6","volume":"110","author":"MR Johnston","year":"1995","unstructured":"Johnston, M. R., Minchen, R. F. & Dawson, C. A. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 110, 368\u2013373, https:\/\/doi.org\/10.1016\/S0022-5223(95)70232-6 (1995).","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"48719_CR27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jtcvs.2013.10.009","volume":"147","author":"Pedro Reck dos Santos","year":"2014","unstructured":"dos Santos, P. R. et al. Modified in vivo lung perfusion allows for prolonged perfusion without acute lung injury. J Thorac Cardiovasc Surg 147, 774\u2013781: discussion 781\u2013772, https:\/\/doi.org\/10.1016\/j.jtcvs.2013.10.009 (2014).","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"key":"48719_CR28","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.athoracsur.2015.12.043","volume":"101","author":"P Reck Dos Santos","year":"2016","unstructured":"Reck Dos Santos, P. et al. Modified In Vivo Lung Perfusion for Local Chemotherapy: A Preclinical Study With Doxorubicin. Ann Thorac Surg 101, 2132\u20132140, https:\/\/doi.org\/10.1016\/j.athoracsur.2015.12.043 (2016).","journal-title":"Ann Thorac Surg"},{"key":"48719_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.aca.2013.08.031","volume":"803","author":"B Bojko","year":"2013","unstructured":"Bojko, B. et al. Solid phase microextraction fills the gap in tissue sampling protocols. Analytica Chimica Acta 803, 75\u201381, https:\/\/doi.org\/10.1016\/j.aca.2013.08.031 (2013).","journal-title":"Analytica Chimica Acta"},{"key":"48719_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.talanta.2018.02.049","volume":"183","author":"A Roszkowska","year":"2018","unstructured":"Roszkowska, A. et al. Equilibrium ex vivo calibration of homogenized tissue for in vivo SPME quantitation of doxorubicin in lung tissue. Talanta 183, 304\u2013310, https:\/\/doi.org\/10.1016\/j.talanta.2018.02.049 (2018).","journal-title":"Talanta"},{"key":"48719_CR31","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1055\/s-2000-8250","volume":"54","author":"TE Murdter","year":"2000","unstructured":"Murdter, T. E. et al. [Pharmacokinetics of cyclophosphamide, adriamycin and adriamycin prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP)]. Pneumologie 54, 494\u2013498, https:\/\/doi.org\/10.1055\/s-2000-8250 (2000).","journal-title":"Pneumologie"},{"key":"48719_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1510\/icvts.2007.152165","volume":"6","author":"C Biancosino","year":"2007","unstructured":"Biancosino, C., Albert, M. & Linder, A. Acute toxicity of irinotecan in the ex-vivo isolated perfused human lung model\u2013high-dose therapy during isolated perfusion without acute toxic lung edema. Interact Cardiovasc Thorac Surg 6, 583\u2013587, https:\/\/doi.org\/10.1510\/icvts.2007.152165 (2007).","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"48719_CR33","doi-asserted-by":"publisher","unstructured":"Ross, J. T., Nesseler, N., Lee, J. W., Ware, L. B. & Matthay, M. A. The ex vivo human lung: research value for translational science. JCI Insight 4, https:\/\/doi.org\/10.1172\/jci.insight.128833 (2019).","DOI":"10.1172\/jci.insight.128833"},{"key":"48719_CR34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/0391398818783391","volume":"41","author":"A Koch","year":"2018","unstructured":"Koch, A. et al. One-year experience with ex vivo lung perfusion: Preliminary results from a single center. Int J Artif Organs 41, 460\u2013466, https:\/\/doi.org\/10.1177\/0391398818783391 (2018).","journal-title":"Int J Artif Organs"},{"key":"48719_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-0029-1245884","volume":"183","author":"F Koch","year":"2011","unstructured":"Koch, F. et al. Ex-vivo human lung tumor model: use for temperature measurements during thermal ablation of NSCLC. Rofo 183, 251\u2013259, https:\/\/doi.org\/10.1055\/s-0029-1245884 (2011).","journal-title":"Rofo"},{"key":"48719_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ejrad.2010.05.017","volume":"80","author":"A Vietze","year":"2011","unstructured":"Vietze, A., Koch, F., Laskowski, U., Linder, A. & Hosten, N. Measurement of ventilation- and perfusion-mediated cooling during laser ablation in ex vivo human lung tumors. Eur J Radiol 80, 569\u2013572, https:\/\/doi.org\/10.1016\/j.ejrad.2010.05.017 (2011).","journal-title":"Eur J Radiol"},{"key":"48719_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1191\/1479972306cd091ra","volume":"3","author":"AR Glanville","year":"2006","unstructured":"Glanville, A. R. Ethical and equity issues in lung transplantation and lung volume reduction surgery. Chron Respir Dis 3, 53\u201358, https:\/\/doi.org\/10.1191\/1479972306cd091ra (2006).","journal-title":"Chron Respir Dis"},{"key":"48719_CR38","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.1016\/j.healun.2017.01.1520","volume":"36","author":"A Iyengar","year":"2017","unstructured":"Iyengar, A. et al. Influence of Ischemic Time on Post Lung Transplant (LT) Outcomes. The Journal of Heart and Lung Transplantation 36, S316, https:\/\/doi.org\/10.1016\/j.healun.2017.01.1520 (2017).","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"48719_CR39","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1164\/rccm.200409-1248OC","volume":"171","author":"G Thabut","year":"2005","unstructured":"Thabut, G. et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 171, 786\u2013791, https:\/\/doi.org\/10.1164\/rccm.200409-1248OC (2005).","journal-title":"Am J Respir Crit Care Med"},{"key":"48719_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jsps.2013.11.002","volume":"23","author":"SK Doke","year":"2015","unstructured":"Doke, S. K. & Dhawale, S. C. Alternatives to animal testing: A review. Saudi Pharm J 23, 223\u2013229, https:\/\/doi.org\/10.1016\/j.jsps.2013.11.002 (2015).","journal-title":"Saudi Pharm J"},{"key":"48719_CR41","doi-asserted-by":"publisher","first-page":"S1871","DOI":"10.21037\/jtd.2018.04.119","volume":"10","author":"M Hsin","year":"2018","unstructured":"Hsin, M. & Au, T. Ex vivo lung perfusion: a potential platform for molecular diagnosis and ex vivo organ repair. J Thorac Dis 10, S1871\u2013S1883, https:\/\/doi.org\/10.21037\/jtd.2018.04.119 (2018).","journal-title":"J Thorac Dis"},{"key":"48719_CR42","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.chest.2017.02.018","volume":"151","author":"S Tane","year":"2017","unstructured":"Tane, S., Noda, K. & Shigemura, N. Ex Vivo Lung Perfusion: A Key Tool for Translational Science in the Lungs. Chest 151, 1220\u20131228, https:\/\/doi.org\/10.1016\/j.chest.2017.02.018 (2017).","journal-title":"Chest"},{"key":"48719_CR43","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1097\/TP.0000000000001798","volume":"101","author":"K Noda","year":"2017","unstructured":"Noda, K. et al. Targeting Circulating Leukocytes and Pyroptosis During Ex Vivo Lung Perfusion Improves Lung Preservation. Transplantation 101, 2841\u20132849, https:\/\/doi.org\/10.1097\/TP.0000000000001798 (2017).","journal-title":"Transplantation"},{"issue":"2","key":"48719_CR44","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.healun.2017.07.001","volume":"37","author":"Tobias Nilsson","year":"2018","unstructured":"Nilsson, T. et al. Comparison of two strategies for ex vivo lung perfusion. J Heart Lung Transplant, https:\/\/doi.org\/10.1016\/j.healun.2017.07.001 (2017).","journal-title":"The Journal of Heart and Lung Transplantation"},{"issue":"2","key":"48719_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.healun.2017.09.021","volume":"37","author":"Clemens Aigner","year":"2018","unstructured":"Aigner, C. et al. Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP301: A prospective, randomized pilot study. J Heart Lung Transplant, https:\/\/doi.org\/10.1016\/j.healun.2017.09.021 (2017).","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"48719_CR46","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.healun.2011.07.014","volume":"30","author":"T Koike","year":"2011","unstructured":"Koike, T. et al. Kinetics of lactate metabolism during acellular normothermic ex vivo lung perfusion. J Heart Lung Transplant 30, 1312\u20131319, https:\/\/doi.org\/10.1016\/j.healun.2011.07.014 (2011).","journal-title":"J Heart Lung Transplant"},{"key":"48719_CR47","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.transproceed.2011.01.122","volume":"43","author":"F Valenza","year":"2011","unstructured":"Valenza, F. et al. The consumption of glucose during ex vivo lung perfusion correlates with lung edema. Transplant Proc 43, 993\u2013996, https:\/\/doi.org\/10.1016\/j.transproceed.2011.01.122 (2011).","journal-title":"Transplant Proc"},{"key":"48719_CR48","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/j.healun.2015.01.257","volume":"34","author":"A Slama","year":"2015","unstructured":"Slama, A. et al. Metabolic Assessment of Marginal Donor Lungs During Ex-Vivo Perfusion (EVLP): New Parameters for Decision Making. The Journal of Heart and Lung Transplantation 34, S97\u2013S97, https:\/\/doi.org\/10.1016\/j.healun.2015.01.257 (2015).","journal-title":"The Journal of Heart and Lung Transplantation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48719-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48719-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48719-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:53:53Z","timestamp":1671281633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48719-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48719"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48719-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12193"}}